NeoImmuneTech, Inc. (KOSDAQ:950220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,142.00
-24.00 (-2.06%)
Jul 18, 2025, 3:30 PM KST
-25.02%
Market Cap112.91B
Revenue (ttm)183.62M
Net Income (ttm)-37.54B
Shares Out98.87M
EPS (ttm)-379.66
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,359,659
Average Volume1,159,086
Open1,166.00
Previous Close1,166.00
Day's Range1,122.00 - 1,215.00
52-Week Range985.00 - 1,881.00
Beta0.80
RSI51.36
Earnings DateAug 14, 2025

About NeoImmuneTech

NeoImmuneTech, Inc., a clinical-stage T cell-focused biotech company, develops and sells immuno-therapeutics. It is developing NT-I7, a clinical-stage long-acting human IL-7 for oncologic and infectious diseases. The company was incorporated in 2014 and is headquartered in Rockville, Maryland. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Employees 52
Stock Exchange KOSDAQ
Ticker Symbol 950220
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.